JiangXi Tianxin Pharm Co Ltd (603235) — Working Capital to Net Assets Ratio
JiangXi Tianxin Pharm Co Ltd (603235) has a Working Capital to Net Assets ratio of 43.7% as of December 2025. Working capital of CN¥2.15 Billion (current assets of CN¥2.78 Billion minus current liabilities of CN¥635.59 Million) is measured against net assets of CN¥4.92 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of JiangXi Tianxin Pharm Co Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
JiangXi Tianxin Pharm Co Ltd Working Capital to Net Assets (2020–2025)
This chart shows how JiangXi Tianxin Pharm Co Ltd's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 43.7%, reflecting working capital of CN¥2.15 Billion against net assets of CN¥4.92 Billion CNY. Check 603235 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for JiangXi Tianxin Pharm Co Ltd (2020–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for JiangXi Tianxin Pharm Co Ltd from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 603235 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 43.7% | CN¥2.15 Billion | CN¥4.92 Billion | CN¥2.78 Billion | CN¥635.59 Million | ▼ -3.7 pp |
| 2024 | 47.3% | CN¥2.19 Billion | CN¥4.62 Billion | CN¥2.70 Billion | CN¥509.78 Million | ▼ -15.5 pp |
| 2023 | 62.8% | CN¥2.66 Billion | CN¥4.23 Billion | CN¥3.12 Billion | CN¥461.33 Million | ▼ -7.5 pp |
| 2022 | 70.4% | CN¥2.86 Billion | CN¥4.06 Billion | CN¥3.17 Billion | CN¥311.18 Million | ▲ +23.1 pp |
| 2021 | 47.3% | CN¥902.34 Million | CN¥1.91 Billion | CN¥1.58 Billion | CN¥677.06 Million | ▲ +33.7 pp |
| 2020 | 13.5% | CN¥156.24 Million | CN¥1.15 Billion | CN¥1.65 Billion | CN¥1.49 Billion | — |